The University of Kentucky’s Department of Surgery will be welcoming several new surgeons to its faculty throughout most of the summer and fall of 2017. One of the most recent to join is Dr. Reese W. Randle, a general surgeon with a specialty interest in endocrine surgery. Dr. Randle commenced his practicing on August 1.

Dr. Randle is originally from Houston, Texas. His father works in the oil industry “like nearly everyone else in Houston.” His mother is a long time school teacher.

The Department of Physiology welcomes our newest faculty!

Erhard Bieberich, PhD
Professor
(previously Augusta University)

Guanghu Wang, PhD
Assistant Professor
(previously Augusta University)

Stefanka Spassieva, PhD
Assistant Professor
(previously Texas A&M)

UK HealthCare’s University of Kentucky Albert B. Chandler Hospital remains the No. 1 hospital in Kentucky and the Bluegrass Region, according to the U.S. News & World Report's Best Hospitals Rankings released today.

In addition, four major health care areas have achieved top 50 national rankings, three of them for the first time. UK HealthCare rankings included: #50 in Cancer, #44 in Neurology and Neurosurgery, #43 in Geriatrics, and #37 in Diabetes and Endocrinology.

On August 2, 2017, NIH released an updated policy eliminating appendix material related to clinical trials for applications submitted to the NIH, AHRQ or NIOSH for due dates on or after January 25, 2018.  The new policy specifies that all information for the peer review process must be contained within the application itself, in the designated section.

Faculty promotions for 2017 at the University of Kentucky Department of Surgery were announced on Thursday, July 27 by department chair Dr. Jay Zwischenberger. They included the following:

Dr. Sandra Beck
Professor

Dr. Joseph Bobadilla
Associate Professor

Dr. William Cavatassi
Associate Professor

Dr. Phillip Chang 
Professor

Dr. Roberto Gedaly
Professor

A new study by University of Kentucky Markey Cancer Center researchers shows that when therapy-sensitive cancer cells die, they release a "killer peptide" that can eliminate therapy-resistant cells.

Tumor relapse is a common problem following cancer treatment, because primary tumor cells often contain therapy-resistance cancer cells that continue to proliferate after the therapy-sensitive cells have been eliminated.

By Kristi Lopez
Link to Original Story in UKnow

This article originally appeared at https://uknow.uky.edu/research/community-transition-program-stroke-survivors-improves-health-saves-money

By Mallory Powell

NIH recently updated the RPPR FAQs page, specifically related to Final RPPRs.  Please review the FAQs here.